A deadly fungus may not live to see the last of us
The battle lines have finally shifted in the war against a deadly fungal disease.
Sep 30, 2026
0
4
Clinical pharmacology news
Experimental obesity drug targets appetite through amylin, offering potential alternative to GLP-1 therapies
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), and published in The Lancet Diabetes & Endocrinology shows that weekly injections ...
Sep 30, 2026
0
34
Higher GLP-1 costs lead to lower adherence
Semaglutides, or GLP-1s, can produce substantial weight loss if individuals adhere to their doctor's instructions. But a new study from the University of Georgia suggests patients aren't taking the weight loss medication ...
Sep 30, 2026
0
4
Machine learning toolkit can improve odds of drug development success
Southwest Research Institute (SwRI) is using a generative artificial intelligence (AI) tool to improve pharmaceutical development outcomes. The SwRI-developed GAMES, or Generative Approaches for Molecular Encodings, uses ...
Sep 30, 2026
0
4
Activating 'energy saver' mode significantly extends lives of animals in preclinical study
Scientists have successfully used a drug to prolong the lifespan of several species of animals, in some cases by more than 25%. The study, published in Aging Cell, found strong evidence that activating a protein that governs ...
Sep 30, 2026
0
12
Research offers new hope for those at higher risk of Alzheimer's disease
A new study from the University of Missouri offers hope for those who are at significantly higher risk of developing Alzheimer's disease later in life.
Sep 30, 2026
0
35
Benzodiazepine prescriptions dropped sharply in the US over the past decade, research finds
The number of prescriptions dispensed for benzodiazepines like Xanax and Valium declined in the United States over the past 10 years, potentially suggesting that doctors have become more cautious about prescribing these sedatives, ...
Sep 30, 2026
0
7
Model reveals strategies to modify the tumor microenvironment and improve cancer therapy
Researchers from Mass General Brigham and the University of Cyprus have developed a mathematical model to better understand how the tumor microenvironment affects the delivery and effectiveness of a new type of cancer therapy ...
Sep 30, 2026
0
3
New opioid up to 10 times stronger than fentanyl spreading across US
A powerful new lab-made opioid is moving through the illegal U.S. drug supply, and federal officials warn it could keep spreading.
Sep 29, 2026
0
5
Severe withdrawal cases point to growing medetomidine use
A powerful veterinary sedative, medetomidine, is increasingly appearing in street supplies of the already deadly opioid fentanyl, and the number of patients suffering from medetomidine withdrawal has quadrupled in recent ...
Sep 29, 2026
0
12
